Use of naphthalene derivatives in treating lung carcinoma

Details Use of naphthalene derivatives in treating lung carcinoma Use of naphthalene derivatives in treating lung carcinoma

1997-03-13

1998-10-13

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514255, 514256, A61K 31495, A61K 3150

Patent

active

058212450

ABSTRACT:
A method of inhibiting cell growth in human small cell lung carcinoma comprising administering to a mammal in need of such treatment a cell growth inhibitory amount of a compound of the formula ##STR1##

REFERENCES:
Cattaneo, Maria G., et al., "Mitogenic effect of serotonin in human cell lung carcinoma cells", European Journal of Pharmacology, Molecular Pharmacology Section 291, pp. 209-211 (1995).
Cattaneo, Maria G., et al., "5-HT.sub.1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma", European Journal of Pharmacology, Molecular Pharmacology Section 268, pp. 425-430 (1994).
Ishibashi, Miyuki, et al., "Inhibition of Growth of Human Small Cell Lung Cancer by Bromocriptine", Cancer Research, 54, pp. 3442-3446, Jul. 1, 1994 .

Affiliated with

Also associated with

Rating

Use of naphthalene derivatives in treating lung carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of naphthalene derivatives in treating lung carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of naphthalene derivatives in treating lung carcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-313419